Back to Journals » Drug Design, Development and Therapy » Volume 14

Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling [Corrigendum]

Authors Yu J, Zhu C, Yin J, Yu D, Wan F, Tang X, Jiang X 

Received 3 March 2020

Accepted for publication 3 March 2020

Published 13 March 2020 Volume 2020:14 Pages 1143—1144

DOI https://doi.org/10.2147/DDDT.S252309



Yu J, Zhu C, Yin J, et al. Drug Des Dev Ther. 2020;14:361–370.

The authors have advised that in Figure 3 on page 365, the image of the Blank group was mistakenly duplicated from the NC group.

Read the original article

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.